{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:39:51Z","timestamp":1791319191725,"version":"4.3.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Catheter ablation (CA) for ventricular tachycardia (VT) can improve outcomes in patients with ischemic cardiomyopathy. Data on patients with non-ischemic cardiomyopathy are scarce. The purpose of this systematic review and meta-analysis is to compare early CA for VT to deferred or no ablation in patients with ischemic or non-ischemic cardiomyopathy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>Studies were selected according to the following PICOS criteria: patients with structural heart disease and an implantable cardioverter-defibrillator (ICD) for VT, regardless of the antiarrhythmic drug treatment; intervention\u2013early CA; comparison\u2013no or deferred CA; outcomes\u2013any appropriate ICD therapy, appropriate ICD shocks, all-cause mortality, VT storm, cardiovascular mortality, cardiovascular hospitalizations, complications, quality of life; published randomized trials with follow-up \u226512 months. Random-effect meta-analysis was performed. Outcomes were assessed using aggregate study-level data and reported as odds ratio (OR) or mean difference with 95% confidence intervals (CIs). Stratification by left ventricular ejection fraction (LVEF) was also done. Eight trials (<jats:italic>n<\/jats:italic> = 1,076) met the criteria. Early ablation was associated with reduced incidence of ICD therapy (OR 0.53, 95% CI 0.33\u20130.83, <jats:italic>p<\/jats:italic> = 0.005), shocks (OR 0.52, 95% CI 0.35\u20130.77, <jats:italic>p<\/jats:italic> = 0.001), VT storm (OR 0.58, 95% CI 0.39\u20130.85, <jats:italic>p<\/jats:italic> = 0.006), and cardiovascular hospitalizations (OR 0.67, 95% CI 0.49\u20130.92, <jats:italic>p<\/jats:italic> = 0.01). All-cause and cardiovascular mortality, complications, and quality of life were not different. Stratification by LVEF showed a reduction of ICD therapy only with higher EF (high EF OR 0.40, 95% CI 0.20\u20130.80, <jats:italic>p<\/jats:italic> = 0.01 vs. low EF OR 0.62, 95% CI 0.34\u20131.12, <jats:italic>p<\/jats:italic> = 0.11), while ICD shocks (high EF OR 0.54, 95% CI 0.25\u20131.15, <jats:italic>p<\/jats:italic> = 0.11 vs. low EF OR 0.50, 95% CI 0.30\u20130.83, <jats:italic>p<\/jats:italic> = 0.008) and hospitalizations (high EF OR 0.95, 95% CI 0.58\u20131.58, <jats:italic>p<\/jats:italic> = 0.85 vs. low EF OR 0.58, 95% CI 0.40\u20130.82, <jats:italic>p<\/jats:italic> = 0.002) were reduced only in patients with lower EF.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Early CA for VT in patients with structural heart disease is associated with reduced incidence of ICD therapy and shocks, VT storm, and hospitalizations. There is no impact on mortality, complications, and quality of life. (The review protocol was registered with INPLASY on June 19, 2022, #202260080).<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>[<jats:ext-link>https:\/\/inplasy.com\/<\/jats:ext-link>], identifier [202260080].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.1063147","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T05:39:45Z","timestamp":1669786785000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Outcomes of early catheter ablation for ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter-defibrillator: An updated systematic review and meta-analysis of randomized trials"],"prefix":"10.3389","volume":"9","author":[{"given":"Tchavdar","family":"Shalganov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milko","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassil","family":"Traykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jacc.2009.03.078","article-title":"Indications for implantable cardioverter-defibrillators based on evidence and judgment.","volume":"54","author":"Myerburg","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2017.03.066","article-title":"Drugs to prevent sudden cardiac death.","volume":"237","author":"Erath","year":"2017","journal-title":"Int J Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.hrthm.2009.11.027","article-title":"Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.","volume":"7","author":"Sweeney","year":"2010","journal-title":"Heart Rhythm."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure.","volume":"359","author":"Poole","year":"2008","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/europace\/eup091","article-title":"Implantable cardioverter defibrillators and their role in heart failure progression.","volume":"11","author":"Cevik","year":"2009","journal-title":"Europace."},{"key":"B6","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jacc.2010.06.059","article-title":"Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.","volume":"57","author":"van Rees","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/europace\/euq316","article-title":"Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management.","volume":"12","author":"Braunschweig","year":"2010","journal-title":"Europace."},{"key":"B8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","article-title":"Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.","volume":"117","author":"Carbucicchio","year":"2008","journal-title":"Circulation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/europace\/euq364","article-title":"Catheter ablation of electrical storm in patients with structural heart disease.","volume":"13","author":"Kozeluhova","year":"2011","journal-title":"Europace."},{"key":"B10","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10840-020-00870-3","article-title":"Radiofrequency catheter ablation of ventricular tachycardia in ischemic heart disease in light of current practice: a systematic review and meta-analysis of randomized controlled trials.","volume":"59","author":"da Silva","year":"2020","journal-title":"J Interv Card Electrophysiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.hroo.2020.08.001","article-title":"Preventive versus deferred catheter ablation of myocardial infarct\u2013associated ventricular tachycardia: a meta-analysis.","volume":"1","author":"Kampaktsis","year":"2020","journal-title":"Heart Rhythm O<sup>2<\/sup>."},{"key":"B12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.113.003063","article-title":"Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the prospective heart centre of leipzig VT (HELP-VT) study.","volume":"129","author":"Dinov","year":"2014","journal-title":"Circulation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/pace.14129","article-title":"Meta-analysis comparing outcomes of catheter ablation for ventricular arrhythmia in ischemic versus nonischemic cardiomyopathy.","volume":"44","author":"Basu-Ray","year":"2021","journal-title":"Pacing Clin Electrophysiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.hrthm.2018.10.028","article-title":"Evaluation and management of ventricular tachycardia in patients with dilated cardiomyopathy.","volume":"16","author":"Ebert","year":"2019","journal-title":"Heart Rhythm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/europace\/euy150","article-title":"Advancement in cardiac imaging for treatment of ventricular arrhythmias in structural heart disease.","volume":"21","author":"Sramko","year":"2019","journal-title":"Europace."},{"key":"B16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B17","year":"2020","journal-title":"The cochrane collaboration review manager (revman). Version 5.4."},{"key":"B18","year":"2022","journal-title":"Jamovi. (Version 2.3) [computer software]."},{"key":"B19","year":"2022","journal-title":"GRADEpro Guideline Development Tool [Software] McMaster University and Evidence Prime"},{"key":"B20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jce.12567","article-title":"Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial.","volume":"26","author":"Al-Khatib","year":"2015","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/europace\/euw096","article-title":"Long-term benefit of first-line peri-implantable cardioverter\u2013defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.","volume":"19","author":"Acosta","year":"2017","journal-title":"Europace."},{"key":"B22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.joa.2014.06.001","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease.","volume":"31","author":"Goya","year":"2015","journal-title":"J Arrhythm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.joa.2014.09.007","article-title":"Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: clinical outcomes after a single endocardial ablation.","volume":"31","author":"Suzuki","year":"2015","journal-title":"J Arrhythm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ihj.2020.09.009","article-title":"Catheter ablation of scar based ventricular tachycardia \u2013 procedural characteristics and outcomes.","volume":"72","author":"Yadav","year":"2020","journal-title":"Indian Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","article-title":"Prophylactic catheter ablation for the prevention of defibrillator therapy.","volume":"357","author":"Reddy","year":"2007","journal-title":"N Engl J Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-673661755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs.","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e004422","DOI":"10.1161\/CIRCEP.116.004422","article-title":"Impact of substrate modification by catheter ablation on implantable cardioverter-defibrillator interventions in patients with unstable ventricular arrhythmias and coronary artery disease: results from the multicenter randomized controlled SMS (substrate modification study).","volume":"10","author":"Kuck","year":"2017","journal-title":"Circ Arrhythm Electrophysiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT) \u2013 a multicenter randomized trial.","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial.","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia.","volume":"79","author":"Arenal","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1161\/CIRCULATIONAHA.122.060039","article-title":"First-line catheter ablation of monomorphic ventricular tachycardia in cardiomyopathy concurrent with defibrillator implantation: the PAUSE-SCD randomized trial.","volume":"145","author":"Tung","year":"2022","journal-title":"Circulation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/jce.13419","article-title":"Quality of life with ablation or medical therapy for ventricular arrhythmias: a substudy of VANISH.","volume":"29","author":"Gula","year":"2018","journal-title":"J Cardiovasc Electrophysiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.hrthm.2017.10.009","article-title":"Impact of ventricular tachycardia ablation on health care utilization.","volume":"15","author":"Winterfield","year":"2018","journal-title":"Heart Rhythm."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/europace\/euz132","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.","volume":"21","author":"Cronin","year":"2019","journal-title":"Europace."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American college of cardiology foundation\/American heart association task force on clinical practice guidelines and the heart rhythm society.","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1063147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T05:39:47Z","timestamp":1669786787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1063147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,30]]},"references-count":36,"alternative-id":["10.3389\/fcvm.2022.1063147"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1063147","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,30]]},"article-number":"1063147"}}